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Nonlinear capacitanceCystic ﬁbrosis transmembrane conductance regulator (CFTR) is a cAMP-activated chloride channel that is
present in a variety of epithelial cell types, and usually expressed in the luminal membrane. In contrast,
prestin (SLC26A5) is a voltage-dependent motor protein, which is present in the basolateral membrane of
cochlear outer hair cells (OHCs), and plays an important role in the frequency selectivity and sensitivity of
mammalian hearing. By using in situ hybridization and immunoﬂuorescence, we found that both mRNA and
protein of CFTR are present in OHCs, and that CFTR localizes in both the apical and the lateral membranes.
CFTR was not detected in the lateral membrane of inner hair cells (IHCs) or in that of OHCs derived from
prestin-knockout mice, i.e., in instances where prestin is not expressed. These results suggest that prestin
may interact physically with CFTR in the lateral membrane of OHCs. Immunoprecipitation experiments
conﬁrmed a prestin–CFTR interaction. Because chloride is important for prestin function and for the efferent-
mediated inhibition of cochlear output, the prestin-directed localization of CFTR to the lateral membrane of
OHCs has a potential physiological signiﬁcance. Aside from its role as a chloride channel, CFTR is known as a
regulator of multiple protein functions, including those of the solute carrier family 26 (SLC26). Because
prestin is in the SLC26 family, several members of which interact with CFTR, we explored the potential
modulatory relationship associated with a direct, physical interaction between prestin and CFTR. Electro-
physiological experiments demonstrated that cAMP-activated CFTR is capable of enhancing voltage-
dependent charge displacement, a signature of OHC motility, whereas prestin does not affect the chloride
conductance of CFTR.e conductance regulator; Fsk,
ner hair cell; NLC, nonlinear
rotein 26
+1 847 491 4795.
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Inner (IHCs) and outer hair cells (OHCs) are the two mechanore-
ceptor cell populations housed in the sensory organ of mammalian
hearing: the organ of Corti. IHCs, which convert the mechanical force
arising from sound waves into neurotransmitter release, are consid-
ered the true sensory receptors for hearing [1]. In contrast, OHCs
undergo rapid somatic length changes when the voltage across their
basolateral membranes is altered [2–5]. This somatic electromotility is
thought to function as a constituent of the cochlear ampliﬁer by
providing local mechanical enhancement of the basilar membrane's
vibratory pattern [1,6]. Prestin is responsible for somatic electro-
motility of OHCs [7], and is essential for normal hearing sensitivity and
frequency selectivity of mammals [8–11]. This OHC motor protein
belongs to a distinct anion transporter family called solute carrierprotein 26 (SLC26). Although prestin's anion transport properties are
controversial [12–15], anions, principally Cl−, are required for
prestin's activity [16,17].
Aside from its reported function in efferent-mediated inhibition
of cochlear output [18], intracellular Cl− in OHCs is essential for
enabling prestin's function and, thus, cochlear feedback ampliﬁcation
[16,17,19]. Consequently, a delineation of Cl− channels and transpor-
ters that are native to OHCs is of interest, especially since they have
not been fully characterized [20]. At present, it is known that
hyperpolarization-activated ClC-2 channels [21,22] and a non-
selective stretch-activated conductance, named GmetL, are present
in the lateral plasma membrane of OHCs [16]. However, one ubiq-
uitous Cl− channel, CFTR, has received relatively meager attention in
the hearing literature. The cystic ﬁbrosis transmembrane conductance
regulator (CFTR) is a chloride channel that regulates ion balance
[23,24]. The gene coding for CFTR is highly conserved among species,
and certain mutations of the gene are responsible for cystic ﬁbrosis
(CF) [25]. Because CFTR is present in a wide variety of cell types, it is
possible that this chloride channel is also present in hair cells. In a
previous study, contribution of the CFTR chloride conductance to the
relatively low membrane resistance found in OHCs was tested and
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that CFTR is present and, when activated, inﬂuences OHCs, since the
regulatory status of CFTR was unknown in this particular experiment.
If the channel were inactivated, one would not observe CFTR's elec-
trophysiological signature. Hence, knowing whether CFTR is present
in OHCs is important for understanding the regulatory mechanisms of
these cells.
Besides being a chloride channel, CFTR is also a regulator of a wide
range of other ion channels and transporters through inhibition or
activation [26]. Recently, several laboratories have reported that CFTR
can interact with members of the SLC26A family including PAT1
(SLC26A6), DRA (down-regulated in adenoma, SLC26A3), and PDS
(Pendred's syndrome, SLC26A4). This interaction has been shown to
affect ion transport by these proteins [27–31]. Inasmuch as prestin
belongs to the SLC26 family, it is possible that prestin function is
modulated by CFTR or vice versa. Because prestin function is essential
for normal hearing in mammals, any of its alterations are of potential
physiological signiﬁcance.
2. Materials and methods
2.1. Chemicals, plasmids, and antibodies
Rabbit polyclonal anti-mPres antibody was raised by immuniza-
tion to a carboxy terminus motif of mouse prestin, which has been
previously characterized [32]. Anti-mPres was used in a 1:2000
dilution in immunoﬂuorescence and Western blot experiments. Anti-
CFTR (H-182), anti-CFTR (M-15), anti-CFTR (AB3555), and anti-CFTR
(M3A7) were purchased from Santa Cruz Biotechnology Inc. (Santa
Cruz, CA), Santa Cruz Biotechnology Inc. (Santa Cruz, CA), Millipore
Corp. (Bedford, MA), and Upstate Biotechnology (Lake Placid, NY),
respectively. Mouse anti-V5 and rabbit anti-V5 were purchased from
Invitrogen (Carlsbad, CA) and Sigma (St. Louis, MO), respectively, and
used in a 1:5000 dilution in immunoﬂuorescence and Western blot
experiments. Texas Red-X phalloidin was purchased from Molecular
Probes (Eugene, OR). Secondary antibodies, Alexa 488 and Alexa-546
conjugated to anti-rabbit IgG and anti-donkey IgG were purchased
from Molecular Probes (Eugene, OR), Pierce (Rockford, Il) or Jackson
Immuno Research (Bar Harbor, ME). Dr. S. Muallem kindly provided
the pcDNA3/CFTR and GFP-CFTR plasmid constructs. Prestin-CFP and
C-tag-prestin plasmid constructs have CFP and His-V5 tags attached to
the C-terminus of prestin [32,33]. The plasmid pcDNA3.1-CAT (Chor-
amphenicol acetyl-transferase)was used as a transfection control in the
expression studies. ATP, cAMP, forskolin (Fsk), and 3-isobutyl-1-
methylxanthine (IBMX) were purchased from Sigma (St. Louis, MO).
CFTR chloride conductance blocker, CFTRinh-172, was purchased from
Calbiochem (La Jolla, CA).
2.2. In situ hybridization
All surgical and experimental procedures were conducted in
accordance with the policies of Northwestern University's Animal
Care and Use Committee and the NIH. The detailed procedures for
producing whole-mount cochlear samples were described in [34].
Brieﬂy, adult mice were cardiac perfused, ﬁrst with heparinized saline
and then with 4% formaldehyde, followed by at least 48 h post-
ﬁxation. Cochleae were dissected and decalciﬁed in 10% EDTA for at
least 24 h. An approximately 300-bp fragment corresponding to the
CFTR cDNA (4306–4565 bp) was cloned into pGEM-7Zf (+). Anti-
sense mRNA was labeled with Dig-UTP using a T7 promoter from the
Dig RNA labeling Kit (Roche Applied Science). Similar length of mRNA
probe made from PGEM-7Zf plasmid without CFTR insert was used as
a negative control. After puriﬁcation of RNA probes with ChromaSpin-
30 columns (Clontech), the Dig-labeled probe was used to hybridize
cochlear tissue. Some samples were mounted on glass slides andviewedwith a standardmicroscope. Imageswere capturedwith a CCD
camera.
2.3. RT-PCR and DNA sequencing
RNA was isolated from intact cochleae of wildtype mice using
the Absolutely RNA®RT-PCR Miniprep Kit (Stratagene). 200–300 ng
total RNA was reverse transcribed to cDNA using Superscript II, RNase
H-Reverse Transcriptase at 42 °C for 90 min. After cDNA creation,
ﬁfteen primers (forward and backward) were used to detect different
coding regions of CFTR. Cycling conditions were as follows: denature
at 95 °C for 1 min followed by 45 cycles at 95 °C for 15 s, 54–58 °C for
30 s and, ﬁnally, 72 °C for 1 to 2 min dependent on primer pair. PCR
products were visualized on a 1% or 2% agarose/EtBr gel and further
puriﬁed for DNA sequencing.
2.4. Immunoﬂuorescence experiments
Separate procedures were used for anti-CFTR antibodies pur-
chased from different sources. For anti-CFTR (H-182, Santa Cruz Bio-
technology Inc.), cochleae were dissected from adult mice in L-15
medium. The bony wall of the cochlear apex was removed to expose
the apical turn of the organ of Corti. The cochlea was ﬁxed with 100%
methanol at−20 °C for 20 min. Cochleae were incubated in blocking
solution (PBS plus 10% normal goat serum) at room temperature for
1 h and then with anti-CFTR (1:200 H-182 from Santa Cruz) at 4 °C
overnight. The tissue samples were then exposed to anti-rabbit-IgG
conjugated with Alexa 488 (1:500) and Texas Red-X phalloidin
(1:2000). For immunostaining with anti-CFTR (Millipore) and co-
immunostaining with anti-CFTR (M-15, Santa Cruz) and anti-mPres,
adult mice were cardiac perfused ﬁrst with heparinized saline and
then with 4% formaldehyde. After ∼2h post-ﬁxation in 4% formalde-
hyde at room temperature, cochleae were dissected and treated with
0.2% Triton X-100/PBS for 30 min. 1% BSA and 10% normal goat or
donkey serum were used to block nonspeciﬁc binding. The tissue
samples were then exposed to anti-CFTR (Millipore) at 1:100 dilution,
or anti-CFTR (M-15, 1:100) plus anti-mPres at 1:10,000 for co-
staining. The tissue samples were then exposed to anti-rabbit-IgG
conjugated with Alexa 488 at 1:500 dilution, and anti-goat-IgG con-
jugated with Alexa546 at 1:500 for co-staining. Samples were
mounted on glass slides with Fluoromount-G (Southern Biotechnol-
ogy Associates, Inc., Birmingham, AL) and observed at room tempera-
ture by object lenses of either 20× (0.5 numerical aperture) or 63×
(1.32 numerical aperture, oil) using a Leica confocal system with a
standard conﬁguration DMRXE7 microscope.
2.5. Cell culture and transient transfection
Plasmids encoding prestin and CFTR cDNA were expressed in
HEK293T cells in a ratio of 1:1. Cells were transiently transfected using
Effectene (Qiagen, Valencia CA) as the transfection reagent as de-
scribed previously [35]. After 48 h of incubation, the transiently
transfected cells were used for NLC measurements or Co-Immuno-
precipitation (Co-IP) experiments.
2.6. Co-immunoprecipitation and immunoblotting
HEK293T cells were transiently transfected with V5-His tagged
prestin and CFTR at a ratio of 1:3. 48 h after transfection, some
transfected cells were treated with 12.2 μM Fsk and 0.1 mM IBMX for
30 min. All cells were lysed in lysis buffer (1× TBS, 0.1% NP40, 1 mM
EDTA, 10 mM phenylmethansulphonylﬂuoride (PMSF), 1× Protease
Inhibitor cocktail pH 7.6) for 1.5 h at 4 °C. Cellular residues were
sedimented at 10,000 g for 15 min and the supernatant applied to
Protein A sepharose beads that had been pre-washedwith lysis buffer.
2 μg anti-V5 was added to the solution, and the beads were incubated
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times with lysis buffer. Prestin was eluted by the addition of 2× LDS
buffer with 0.1 M DTT and incubated at 37 °C for 30 min. Fractions
were run on a 7.5% Next gel and blotted with either anti-V5 or anti-
CFTR (M3A7). Cochleae derived from adult wildtype and prestin-KO
mice [36] were dissected in L-15 or L-15 medium containing 12.2 μM
Fsk and 0.1 mM IBMX. Procedures for handling cochlear samples were
similar to those for HEK293T cells except cell lysates were solubilized
with 8% perﬂuorooctanoate (PFO) for 4 days. The lysates were pre-
cipitated by anti-CFTR (H182 or M3A7)/Protein A sepharose. Eluted
proteins from Protein A sepharose were run on LDS-PAGE along with
reducing reagents β-mercaptoethanol and DTT or EDT [37] and
blotted with anti-mPres.
2.7. Electrophysiology
Voltage-dependent membrane capacitance was measured from
HEK293T cells 48 to 72 h after transfection or from mouse OHCs
within two hours after isolation. For preparing OHCs, adult mice were
euthanized with euthasol, and OHCs were isolated in the same way
as described before [38]. Whole-cell recordings were performed using
the Axopatch 200B ampliﬁer (Molecular Devices, Sunnyvale, CA) at
room temperature. Recording pipettes were pulled from borosilicate
glass to achieve initial bath resistances averaging 2–3 MΩ for
HEK293T cells and 4–5 MΩ for OHCs, and were ﬁlled with an
intracellular solution (ICS) containing (mM): 140 CsCl, 2 MgCl2, 10
EGTA, and 10 HEPES. Cells were bathed during whole-cell record-
ings in an extracellular solution (ECS) containing (mM): 120 NaCl, 20
TEA-Cl, 2 CoCl2, 2 MgCl2, 10 HEPES, and 5 glucose. Osmolarity and pH
of both ICS and ECSwere adjusted to 300 mOsm−1 (with glucose) and
7.3, respectively. Data were collected using jClamp software (SciSoft
Company, New Haven, CT). Membrane capacitance was measured by
a two-sine voltage stimulus (390.6 and 781.2 Hz with 10 mV ampli-
tude) superimposed onto a sinusoidal stimulus (2.5 Hz with 120 mV
amplitude) with holding potential at 0 mV. OHCs and HEK293T cells
expressing prestin exhibit nonlinear capacitance (NLC), and the
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where Qmax is the maximum charge transfer, Vpk is the voltage at
which half maximum charge is moved, Clin is the linear capacitance of
a cell, and α (=ze/kBT) is the slope factor of the voltage-dependence
of charge transfer where kB is Boltzmann's constant, T is absolute
temperature, z is valence, and e is electron charge. GraphPad PRISM
software was used for curve ﬁtting analysis of NLC. For activation of
CFTR, 0.2 mM cAMP, 1 mM ATP, and 50 μM IBMX were added to the
intracellular pipette solution, both in HEK293T cells and OHCs. For
recording NLC in HEK293T cells in the presence of cAMP/ATP/IBMX,
CFTRinh-172 (less than 10 μM, see below) was included in the ECS to
maintain the membrane resistance higher than 50 MΩ because low
membrane resistance (thus high membrane conductance) interferes
with the measurement of NLC. Because DMSO affects prestin function
[39], ethanol was used to prepare 1 mM CFTRinh-172 stock solution
although ethanol did not completely dissolve CFTRinh-172. After
adding 10 μM-equivalent CFTRinh-172 to the ECS, a signiﬁcant amount
of CFTRinh-172 crystal was observed, suggesting that the actual
concentration of CFTRinh-172 in ECS was very low (≪10 μM). This
explains the slow kinetics of chloride conductance blockage exem-
pliﬁed in Fig. 8.
Voltage-dependent current was measured from HEK293T cells 48
to 72 h after transfection in a whole-cell conﬁguration at room tem-
perature. Recording pipettes with initial bath resistance of 2–3 MΩwere ﬁlledwith ICS containing (mM): 10 CsCl, 87 Na2SO4, 2MgCl2, 10
EGTA, and 10 HEPES. Cells were bathed during whole-cell recordings
in ECS containing (mM): 87 Na2SO4, 10 TEA-Cl, 2 CoCl2, 2 MgCl2, and
10 HEPES. Since the chloride conductance upon CFTR activation with
the ICS and the ECS used for the NLC measurements was very high,
and the contribution of the series resistance (Rs) to the observed
conductance was signiﬁcant in some recordings, reduced chloride
solutions were used. Osmolarity and pH of both ICS and ECS were
adjusted to 300 mOsm−1 (with glucose) and 7.3, respectively.
0.2 mM cAMP, 1 mM ATP, and 50 μM IBMX were added to the
intracellular pipette solution for activation of CFTR. Activation of
CFTR was monitored by tracking the reduction of membrane
resistance. After the CFTR activation reached a plateau, voltage-
dependent current was measured by stepping from −60 mV to
+60 mV (500 ms duration in 20 mV increments) at 0 mV holding
potential. Data were corrected for the Rs. The conductance was
obtained from the slope of the current–voltage relationship and
divided by the membrane capacitance for comparison of data from
different cells.
2.8. Statistical analysis
Whether prestin-dependent charge movement is signiﬁcantly
enhanced by the activation of CFTR or not was evaluated by the
following t-test using the NLC data obtained at the end of each time
course.
t = Qrel−1ð Þ = SEtrans
Qrel is the relative magnitude of Qmax compared to the Qmax that
was measured right after establishing the whole-cell conﬁguration.
SEtrans is the standard error of the Qrel value representing the error
transmission for calculating Qrel together with the uncertainty of the
Qmax determination. The p-values were calculated from the Student's
t-distribution by using the t value deﬁned above. p-values smaller
than 0.05 were accepted as signiﬁcantly different.
3. Results
3.1. CFTR mRNA and protein are expressed in IHCs and OHCs
In situ hybridization is a technique used to detect, visualize and
localize speciﬁc mRNA at the cellular level. Therefore, we used this
method to examine cochlear CFTR mRNA distribution. Fig. 1 shows
portions of a whole-mount cochlea stained with a control probe and
anti-sense probe for CFTR. As shown in Fig. 1A and C, CFTR mRNA
(brown color) was detected in both types of hair cells. A negative-
control probe produced no staining (Fig. 1B and D). These data suggest
that CFTR mRNA is expressed in IHCs and OHCs. Consistent with this
result, mRNA of CFTR was also detected by PCR in the cochlea
(see Supplemental material Fig. S1).
We further examined CFTR protein expression in the organ of Corti
using immunoﬂuorescence. As shown in Fig. 2, green ﬂuorescence
(indicating CFTR protein) is found mostly in OHCs and IHCs (Fig. 2A).
These data suggest that CFTR protein is expressed in IHCs and OHCs,
consistent with the CFTR mRNA expression pattern (Fig. 1). High
magniﬁcation immunoﬂuorescence images reveal CFTR protein
expression in the cytoplasm and the lateral membrane of OHCs as
indicated by arrowheads in Figs. 2C and 3. In contrast, there is no
staining in the lateral membrane of IHCs, i.e., the labeling predomi-
nates at the apex of the cell as shown in Fig. 2E–K, which are images
taken from the same cells. Figs. 2J and K show three IHCs, as examples,
where no green stain (CFTR label) was found in the lateral membrane
(indicated by small arrowheads). Thus, the subcellular localization of
CFTR is different for OHCs and IHCs.
Fig. 1. CFTRmRNA expression in the cochlea. Adult mouse cochleae were treated with either an anti-sense probe for CFTR (A and C) or a control probe (B and D). A–B. Whole-mount
cochlea taken with a 20× objective. C–D. Whole-mount cochlear sample taken using a 50× objective. Brown staining indicates the presence of CFTR mRNA.
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wildtype OHCs
CFTR is an apical-membrane protein expressed in various epi-
thelial cells [40]. It is uncommon for CFTR to be seen in the lateral
membrane of polarized epithelial cells, such as OHCs [41]. It is,
therefore, possible that a CFTR isoform exists in OHCs and that this
isoform prefers the lateral membrane location. This possibility was
investigated by using RT-PCR to explore the presence of a splicing
isoform of CFTR, using organ of Corti cDNA as template material.
Fifteen primer pairs, covering the entire CFTR coding region, were
used for RT-PCR experiments. The PCR products were further
sequenced to conﬁrm the DNA content. No CFTR isoform was
discovered.Fig. 2. CFTR protein expression in the cochlea. CFTR is stained with anti-CFTR (green color,
Probes). A–B. Immunoﬂuorescence (A) and the corresponding phase-contrast images (B) o
ﬂuorescence (C) and the corresponding phase-contrast images of a whole-mount coch
arrowheads. E–I. Immunoﬂuorescence (E and F) and the corresponding phase-contrast i
cochlear samples, allowing some hair cells to lie ﬂat on the slide. As a result, a quasi side
F (red). I. Superimposed images from E, F and H (phase contrast). J–K. These images corres
examination of the lateral membrane of IHCs (arrowheads). Bar length: 20 µm (A, C, andBecause it appears likely that interaction between prestin and CFTR
changes CFTR's location, we examined CFTR expression in wildtype
OHCs and OHCs derived from prestin-KO mice, in which the prestin
protein is absent [9,10]. As shown in Fig. 3, CFTR protein is clearly
expressed in the apical surfaces of both wildtype OHCs (Fig. 3I–L) and
prestin-KO OHCs (Fig. 3M–P). However, CFTR is not found in the lateral
membrane of OHCs derived from prestin-KOmice (Fig. 3E and G), even
though the typical “ring” staining pattern (shown by arrowheads), is
consistently found in OHCs derived fromwildtypemice (Fig. 3A and C).
Since the ring-likepattern could conceivably result fromexclusionof the
stain by the nucleus (unstained center = nucleus), we also examined
OHC CFTR staining patterns from a radial view. OHCsweremanipulated
to lieﬂat on a slide. Radial views of OHCs also showed that CFTR staining
was found in wildtype OHC lateral membranes (Fig. 3I–L), but not inH182, Santa Cruz). Actin is stained with Texas Red-X phalloidin (red color, Molecular
f a whole-mount cochlea taken at a low magniﬁcation (20× objective). C–D. Immuno-
lea show a cross section of OHCs. The lateral membrane of OHCs is indicated by
mages (H) of a whole-mount cochlea. Mechanical manipulation was used to adjust
-sectional image of IHCs was obtained. G. Superimposed images from E (green) and
pond to the locations marked with “*” and are given at higher magniﬁcation for better
E) and 7 µm (J).
Fig. 3. CFTR localizes to the basolateral membrane of wildtype OHCs. Immunoﬂuorescent images of mouse OHCs derived from wildtype and prestin-KO mice are stained with anti-
CFTR (for CFTR, green) and Texas Red-X phalloidin (for actin, red). A–H. Immunoﬂuorescent and corresponding phase-contrast images taken at the cell-body position from whole-
mount cochlear preparations. A–D.Wildtype cochlea. E–H. Prestin-KO cochlea. A and Ewere stainedwith anti-CFTR (against 1–182 a.a of CFTR, from Santa Cruz). C and Gwere stained
with anti-CFTR (against 1468–1480 a.a of CFTR, fromMillipore). I–P. Immunoﬂuorescent and corresponding phase-contrast images taken from radial views of OHCs stainedwith anti-
CFTR (Santa Cruz) and Texas Red-X phalloidin. I–L. Wildtype OHCs. M–P. Prestin-KO OHCs. Green (CFTR) and red (actin) images were superimposed in K and O. Bar length: 12 µm.
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often associated with an antibody's lack of speciﬁcity, we used two
antibodies against different antigens located at different locations
of CFTR: 1–182 a.a. (H-182) (see Fig. 3A and E) and 1468–1480 a.a.
(AB3555) (see Fig. 3C and G) in order to control for this potential error.
Wedemonstrated that these twoanti-CFTRantibodies donot cross react
with prestin protein (see supplemental material Fig. S2). Thus, ex-
perimental results using either antibody suggest that CFTR is found in
the apical regions of bothOHC genotypes (WT: Fig. 3I–L, KO: Fig. 3M–P),
but only in basolateral membranes of wildtype OHCs where prestin is
abundantly expressed. To further test for the coexistence of CFTR and
prestin in the lateral membrane of OHCs, we co-immunostained CFTR
and prestin in OHCs (Fig. 4). As expected, the ring-like staining pattern
of CFTR was evident (Fig. 4A), which overlaps with the prestin staining
in the lateralmembrane (Fig. 4 B andC). These results conﬁrm that CFTR
is indeed present in the lateral membrane of OHCs and that this
expression is associated with the presence of prestin.
3.3. Prestin binds CFTR
Given that the presence of prestin in OHCs changes the dis-
tribution of CFTR membrane targeting in polarized cells, it is ofinterest to determine whether prestin and CFTR bind together. There-
fore, cochlear samples collected from both wildtypemice and prestin-
KO mice were used for co-immunoprecipitation experiments with
anti-CFTR/Protein A sepharose. Because the interaction between
CFTR and DRA (SLC26A3) is known to be controlled by the regulatory
state of CFTR [30], cochlear samples were dissected both in the
presence and absence of forskolin (Fsk) and 3-isobutyl-1-methylxan-
thine (IBMX). The immunoprecipitated proteins were separated on
LDS-PAGE gel and blotted with anti-mPres. As shown in Fig. 5A, the
prestin monomer band (slightly less than 100 kDa) was found in
wildtype cochleae, suggesting that prestin can bind activated CFTR.
Prestin co-immunoprecipitation with anti-CFTR/Protein A sepharose
was also observed without Fsk/IBMX treatment (data not shown).
The results suggest that prestin can bind CFTR irrespective of the
regulatory status of CFTR. We conﬁrmed the prestin–CFTR binding in
an in vitro system, whereby HEK293T cells were co-transfected with
the V5-His tagged prestin and CFTR (Fig. 5B). The CFTR-prestin inter-
action was analyzed by a co-immunoprecipitation assay using anti-
V5/Protein A sepharose (Fig. 5B). Multiple prestin bands were due to
oligomerization/glycosylation of prestin that were repeatedly ob-
served in mammalian cell lines [37,42]. CFTR protein (∼170 kDa [43])
coprecipitated with prestin irrespective of the Fsk/IBMX treatment,
Fig. 4. Co-immunostaining of CFTR and prestin in OHCs. CFTR and prestin were co-stained with anti-CFTR (red, M-15, Santa Cruz) and anti-mPres (green), respectively. A. CFTR
staining. B. Prestin staining. C. Superimposed image from A and B. D. Phase-contrast image. The ring-like staining pattern for CFTRwas not observed in OHCs derived from prestin-KO
mice (not shown). The results are consistent with the observations in the preceding ﬁgures (Figs. 2 and 3).
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prestin regardless of its regulatory state. The prestin–CFTR binding
was further conﬁrmed using anti-CFTR/Protein A sepharose (data not
shown). The results are consistent with the colocalization of CFTR and
prestin observed in the lateral membrane of OHCs (Figs. 2 and 3). To
exclude possible artifacts caused by the in vitro overexpression
system, prestin was also co-expressed with a non-interacting protein,Fig. 5. Prestin binds CFTR. A. Co-IP experiment: Cochlear samples derived from wildtype (W
CFTR/Protein A sepharose. The immunoprecipitated proteins were then subjected to LDS-PA
100 kDa) was found in WT, but not in KO samples. A similar result was obtained in the ab
solubilized fraction of HEK293T cells transfected with V5-His tagged prestin and CFTRwas inc
PAGE, and blotted with anti-V5 (for prestin) and anti-CFTR, respectively. 1: HEK293T cells
CFTR. 3: HEK293T cells transfected with V5-His tagged prestin and CFTR that were treatedα-tectorin, in HEK293T cells. We conﬁrmed that α-tectorin is not co-
immunoprecipitated with prestin (data not shown).
3.4. Modulation of prestin function by CFTR
Cl− and OH−/HCO3− transport by members of the SLC26 family,
including DRA (SLC26A3), PDS (SLC26A4), and PAT1 (SLC26A6), isT) and prestin-KO (KO) were treated with Fsk/IBMX, and were incubated with anti-
GE, and the membrane was blotted with anti-mPres. A prestin band (slightly less than
sence of Fsk/IBMX treatment (data not shown). B. Pull down experiment: Detergent-
ubated with anti-V5/Protein A sepharose. Precipitated proteins were separated on SDS-
transfected with CFTR. 2: HEK293T cells transfected with V5-His tagged prestin and
with 12.2 μM FSK and 0.1 mM of IBMX.
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another SLC26 family member, prestin (SLC26A5), also interacts with
CFTR. Thus, it is of interest to test if prestin's function is modulated by
CFTR. To this end, we measured NLC of HEK293T cells expressing
either prestin or prestin/CFTR. For identifying cells expressing these
proteins, we used CFP-tagged prestin and GFP-tagged CFTR. The het-
erologous expression of prestin conferred typical nonlinear capaci-
tance (NLC) on the HEK293T cells as previously reported [7],
suggesting that the CFP tag does not interfere with the function of
prestin (Fig. 6A). Cells expressing both prestin and CFTR also showed
NLC, which was similar to that of cells expressing only prestin
(Fig. 6B). Because individual HEK293T cells differ in size, and because
larger cells tend to express a larger number of prestin molecules, we
calculated the charge density (the maximum charge displacement
(Qmax) divided by the linear capacitance of a cell (Clin, which is
proportional to the surface area of the cell), and used this metric for
comparison (Fig. 6C). There was no statistically signiﬁcant difference
(p=0.71) in charge density between cells expressing only prestin
(n=11) and cells expressing both prestin and CFTR (n=11), sug-
gesting that the mere presence of CFTR has no modulatory effect on
the charge displacement function of prestin. As a control, we also
measured voltage-dependent capacitance of cells expressing only
CFTR, and found that mere expression of CFTR did not confer NLC on
the cells. This latter result was found for both activated and inactive
CFTR (data not shown).
The effect of activated CFTR on prestin functionwas also studied. In
these experiments, the cell was dialyzed in the whole-cell conﬁgu-
ration, with cAMP/ATP/IBMX-containing intracellular solution in
order to activate CFTR. As expected, cells overexpressing CFTR showed
drastic decrements in membrane resistance, due to increased chloride
conductance, as exempliﬁed in the inset of Fig. 7A. We measured NLC
of individual cells expressing both prestin and CFTR at different time
points during the CFTR activation (Fig. 7A). As summarized in Fig. 7C,
Qmax (the maximum charge translocated) showed an increase. In
control cells overexpressing only prestin (Fig. 7B and D), neither
a rapid decrement in the membrane resistance, nor an increment
in Qmax was observed. The Qmax enhancements seen in cells
overexpressing both prestin and activated CFTR were statisticallyFig. 6. Quiescent CFTR does not affect prestin function. A, B. Examples of NLC measured o
(B). C. Summary of charge density. Bars indicate mean and standard deviation.signiﬁcant (pb0.05) for all recordings (Fig. 7C, n=5, see Materials
and methods), whereas those without CFTR co-expression were not
(p=0.33–0.94) (Fig. 5D, n=6). Statistically signiﬁcant difference was
also manifested on the mean relative Qmax value taken at the end of
each time course between cells overexpressing both prestin and CFTR
vs. cells overexpressing only prestin (p=0.016) (Fig. 7E). These
results strongly suggest that activated CFTR enhances the function of
prestin, as found for other members in the SLC26 family, including
DRA and PAT1 [31]. This enhancement is manifested as increased ion
transport for other SLC26A members, but as increased charge transfer
(motility) for prestin (SLC26A5). An alternative interpretation of the
data might be that the increase in Qmax resulted from an increase in
the number of prestin molecules in the cell membrane due to exocytic
membrane trafﬁcking of vesicles containing extra prestin/CFTR
molecules during the measurement. Although exocytic vesicle trans-
port induced by CFTR activation is a contentious issue [41,44], we did
not observe any increment in linear membrane capacitance upon
cAMP/ATP/IBMX stimulation in HEK293T cells expressing CFTR (data
not shown). It should be noted that the kinetics of CFTR exocytic
membrane transport [45–49] is much slower than that of the Qmax
enhancement (Fig. 7C), indicating that the Qmax change was not
induced by CFTR-dependent membrane transport if, in fact, any
occurred. Furthermore, the possibility of cAMP-dependent exocytic
vesicle transport is not supported by our control measurements
(Fig. 7B and D), in which we observed neither a rapid decrement in
the membrane resistance, nor an increment in Qmax. These results
indicate that the increasing Qmax is indeed activated CFTR dependent,
i.e., it is not caused by extra prestinmolecules being transported to the
cell membrane during the measurement. The control experiment is
also contrary to the possibility that the Qmax change was induced by
equilibration of cells with the intracellular solution during the
measurements. The degree of Qmax enhancement was highly variable
among cells. This likely reﬂects differences in the molar ratio of
prestin and CFTR expressed in individual transfected cells. If the
activation of prestin were achieved by a stoichiometric prestin–CFTR
physical interaction, then the degree of change in Qmax should depend
on the availability of CFTR to each prestin molecule: too much prestin
over CFTR would attenuate the overall apparent relative Qmax changen HEK293T cells expressing either prestin-CFP (A) or both prestin-CFP and CFTR-GFP
Fig. 7. Effect of CFTR activation on prestin function. The intracellular pipette solution contained 0.2 mM cAMP, 1 mM ATP, and 50 μM IBMX for activation of CFTR. Time-dependent
NLC was measured on HEK293T cells expressing either prestin-CFP (B and D) or both prestin-CFP and CFTR-GFP (A and C). A, B. Examples of the time-dependent NLCmeasurements.
The insets show time course of the membrane resistance (Rm) changes. The NLC recordings were performed at the time points indicated (▲) after establishing whole-cell
conﬁguration. C, D. Time-dependent relative Qmax values with respect to the Qmax measured at the beginning of the time course. Each symbol represents a different cell. The error
bars indicate the accuracies of the relative Qmax values calculated from the standard errors of the curve ﬁttings of the original NLC data, some of which are too small to be seen. Only
three representative results (out of six recordings) are shown in D for clarity. The red symbols show the data points obtained from the time-dependent NLC recordings shown in
A and B. E. Summary of the Qmax change. The data point at the end of each time course was summarized for comparison. The average relative Qmax value was 1.81±0.64 (mean±s.d.,
n=5) for cells overexpressing both prestin and CFTR, and 1.03±0.06 (mean±s.d., n=6) for cells overexpressing only prestin. Student's t-test found a signiﬁcant difference
(p=0.016) in the average relative Qmax, but not for α and Vpk values (pN0.05). In fact, all Qmax increments observed in individual cells overexpressing both prestin and CFTR were
statistically signiﬁcant (pb0.05), while all of those observed in cells overexpressing only prestin were not.
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Estimation of the prestin/CFTR expression in the plasmamembrane of
individual cells was difﬁcult because ﬂuorescence was often found
in the cytosolic compartment due to overexpression of the proteins.
Separating ﬂuorescence signals in the plasma membrane from those
in the cytosol was not feasible with the epi-ﬂuorescence microscope
used for the electrophysiological recordings.
Another characteristic aspect of the Qmax enhancement is its delay.
The Qmax change did not occur contemporaneously with the mem-
brane resistance change. The membrane resistance plummeted
immediately after establishing the whole-cell conﬁguration, whereas
the relative Qmax did not noticeably increase for approximately 10 s
after establishing the whole-cell conﬁguration (Fig. 7C). This suggests
that the increment in Qmax is a result of sequential cellular events,
probably consisting of rapid increment of cAMP, PKA activation by
cAMP, phosphorylation of the R domain of CFTR, and interaction of the
activated CFTR with prestin. Hence, the delay is inconsistent with the
idea that the increased Qmax was somehow related to the rapidly
decreasing membrane resistance during the NLC measurements. To
further check the inﬂuence of rapidly decreasing membrane resis-
tance on the time-dependent NLC measurements, we monitored
NLC over a longer time course during which chloride conductance
was blocked by the CFTR-speciﬁc chloride conductance blocker,
CFTRinh-172 (Fig. 8). As blocking of the CFTR chloride conductanceincreased over time, the membrane resistance eventually returned to
its initial level. The Qmax, however, stayed higher than its initial value,
supporting the validity of our NLC measurements (Fig. 7) and the
sequence of biochemical events associated with the direct, physical
interaction between prestin and CFTR.3.5. Effect of prestin on CFTR activity
It has been reported that DRA and PAT1 potentiate the con-
ductivity of CFTR by increasing the channel open probability. To-
gether with the evidence of prestin–CFTR interaction, it is of
interest to see if prestin is also capable of reciprocally modulating
the function of CFTR. To this end, we measured the conductance of
cells expressing only CFTR and cells expressing both CFTR and
prestin. Conductance was determined from the voltage-dependent
current measured after CFTR activation by the intracellularly applied
cAMP/ATP/IBMX (Fig. 9). For proper comparison (i.e., to account
for differing cell sizes), the conductance was normalized by the
membrane capacitance of the cells. As shown in Fig. 9C, a statistically
signiﬁcant difference was not evident between the two groups
(n=30 for CFTR, n=34 for CFTR/prestin p=0.21), suggesting
that prestin has little modulatory effect on the chloride conductance
of CFTR.
Fig. 8. Qmax enhancement by activated CFTR with blocked chloride conductance. Time-
dependent NLC was measured on HEK293T cells expressing both prestin-CFP and CFTR-
GFP. The intracellular pipette solution contained 0.2 mM cAMP, 1 mM ATP, and 50 μM
IBMX for rapid activation of CFTR. The recording started after establishing a whole-cell
conﬁguration. A low concentration of CFTRinh-172 (≪10 μM, see Materials and
methods) was included in the bath solution to block the chloride conductance of
CFTR. The initial rapid increment of chloride conductance was not completely blocked
by CFTRinh-172, and was followed by a slow attenuation. This is because of the very low
concentration of CFTRinh-172 (see Materials and methods), and because the open state
of CFTR is favorable for CFTRinh-172 action [63]. The broken line indicates the initial
resistance level. Qualitatively similar results were obtained on different cells (n=3).
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Effect of CFTR activation on charge movement was also studied in
isolated OHCs using the same experimental procedure as for theFig. 9. Effect of prestin on CFTR. The intracellular pipette solution contained 0.2 mM cAMP
measured on HEK293T cells expressing either CFTR-GFP (A) or both CFTR-GFP and prestin
varied among recordings, a statistically signiﬁcant difference was not observed between (A
slope corrected by the series resistance (Rs), and divided by the membrane capacitance (C
deviation.HEK293T cell recording described above. As expected, reduction
of membrane resistance was observed upon PKA activation
(Fig. 10A, inset) though the degree of the decrement was smaller
than that observed for HEK cells in which CFTR was overexpressed
(Figs. 7A and 8). In some OHCs, however, reduction of the membrane
resistance was not evident (7 out of 20 recordings). Because it is
known that phosphorylation of CFTR by PKC modulates the activation
of CFTR by PKA [50], this may reﬂect a lack of basal PKC phosphory-
lation of CFTR in those cells. Reduction of the membrane resistance
was not observed for control recordings without cAMP in the pipette
solution (Fig. 10B, inset). Time-dependent NLC was measured to
monitor prestin activity with and without cAMP/ATP/IBMX stimula-
tion as exempliﬁed in Fig. 10A and B. The lower noise of the
NLC measurements is mainly due to 5–10 times higher prestin ex-
pression density in OHCs compared to HEK cells. Vpk shift during the
ﬁrst 10–20 s was observed in most recordings, which is likely due to
dialysis of the cytosol with the pipette solution and/or due to negative
pressure [51] transiently applied for establishing the whole-cell con-
ﬁguration. The Vpk shift was not evident in most HEK cells probably
due to use of recording pipettes with wider tips (see Materials
and methods). Because the Vpk shift was also observed without
CFTR activation (Fig. 10B), this initial transient Vpk shift is not related
to prestin–CFTR interaction. Contrary to the results on HEK293T
cells, drastic Qmax enhancements were not observed in OHCs with
cAMP/ATP stimulation.We could not observe a statistically signiﬁcant
Qmax enhancement for OHC recordings regardless of the magnitude
of the membrane resistance reduction. For comparing the relative
Qmax changes induced by cAMP/ATP stimulation to those without, 1 mM ATP, and 50 μM IBMX for activation of CFTR. Voltage-dependent current was
-CFP (B) at time points indicated (▲). Although the initial membrane resistance levels
) and (B). C. Statistics of the measurements. Conductance was calculated from the I–V
m). Each symbol represents an individual recording. Bars indicate mean and standard
Fig. 10. Effect of CFTR activation on prestin function in isolated OHCs. Time-dependent NLC was measured on isolated OHCs. A. An example of the time-dependent NLC
measurements when the intracellular pipette solution contained 0.2 mM cAMP, 1 mMATP, and 50 μM IBMX for activation of CFTR. The inset shows the time course of themembrane
resistance (Rm). After establishing a whole-cell conﬁguration, recordings were taken at the time points indicated (▲). B. An example of the time-dependent NLC measurements
without CFTR activation. C. Time-dependent relative Qmax values with respect to the Qmax measured at the beginning of the time course. Four results are shown for each condition.
Error bars indicate variability of the relative Qmax values calculated from the standard errors of the curve ﬁttings of the original NLC data, many of which are too small to be seen. The
red symbols show the data points obtained from the time-dependent NLC recordings shown in A and B. D. Summary of the Qmax change. The data point at the end of each time course
was chosen for comparison. For results obtained with CFTR activation, only results showing decrease in membrane resistance were used for the statistical analysis (13 out of 20). The
average relative Qmax values were 1.03±0.01 (mean±s.d., n=13) for recordings with CFTR activation, and 1.03±0.06 (mean±s.d., n=12) for recordings without CFTR activation.
The Student's t-test failed to ﬁnd a signiﬁcant difference (p=0.77). A statistically signiﬁcant difference was also not found for α or Vpk values (pN0.05).
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in membrane resistance with application of cAMP/ATP (7 out of 20
recordings). Statistically signiﬁcant difference was not observed
(Fig. 10D). This negative result may imply that additional phos-
phorylation (or dephosphorylation) of CFTR is required for prestin
activation (see Discussion).
4. Discussion
In the present study, we found that CFTR is present in both
the apical and the basolateral membranes of OHCs, and that CFTR
physically associates with prestin. Although CFTR typically resides in
the apical membrane in epithelial cells, CFTR has been reported to
localize to the basolateral membrane. For example, CFTR is targeted to
either apical or basal gill membranes, as well as the intestinal epithelia
of teleost ﬁsh depending on the salinity of the cell's environment [52].
These data suggest that the ﬁnal location of CFTR can be modiﬁed by
other factors. It is likely that the basolateral localization of CFTR in
OHCs is directed by binding of CFTR to prestin, which is exclusively
present in the lateral wall. The difference in the immunoﬂuorescencelabeling observed between IHCs (apical only), OHCs (both apical and
basolateral) and prestin-KO OHCs (apical only) supports this con-
tention (Figs. 2 and 3).
Since intracellular chloride is essential for prestin to generate
signiﬁcant nonlinear charge movement [17], the presence of CFTR in
the close vicinity of prestin has an immediate physiological implica-
tion, i.e., regulating prestin's function by controlling local chloride
concentration around the prestin molecules. Although the intracellu-
lar chloride concentration in OHCs is estimated to be 10 mM or less
[19], this value may be much lower in the subplasmalemmal space,
given the anatomical architecture of the OHC's cortical lattice [53].
Because prestin's chloride binding afﬁnity is 3∼6 mM [17,19,54],
there is a potential for indirectly modulating prestin's function
by local alteration of intracellular chloride concentration [16]. For
example, activation of CFTR in the OHC's lateral membrane could
increase chloride concentration around prestin molecules so that
prestin exerts a larger mechanical response to the same voltage
stimulus. However, experimental proof of this scenario is not readily
feasible because replacement of chloride ions with other anions, while
maintaining ionic strength and minimizing junction potential during
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words, anions that simply replace chloride without affecting prestin's
state-probability function have not been found. Because of the lack of
knowledge as to how different anions interact with prestin, onewould
not be able to correctly attribute an apparent change in themagnitude
of nonlinear charge movement to change in local chloride concen-
tration. Therefore, in this report, NLC measurements were performed
under saturated and equal chloride concentrations across the cell
membrane. This allows us to investigate the effects of a direct, phys-
ical interaction between CFTR and prestin molecules. In other words,
our study does not exclude the possibility that regulation of [Cl−]i
by CFTR indirectly modiﬁes prestin's functions under physiological
conditions.
Another implication of the prestin-directed CFTR localization in
the lateral membrane is its potential physiological role in the OHC's
response to efferent signals. It is known that high chloride found
in perilymph is important for the efferent-mediated inhibition of
cochlear output [18]. In OHCs, the lateral membrane, but not the
apical membrane, faces perilymph. Thus, the prestin-directed lateral
membrane localization of CFTR found in OHCs is interesting. Besides
acetylcholine and γ-aminobutyric acid (GABA), calcitonin gene-
related peptide (CGRP) is known as an efferent neurotransmitter for
OHCs. It has been demonstrated that activation of CGRP receptors
results in activation of CFTR by increasing intracellular cAMP level
[56]. Therefore, it is possible that CFTR in the lateral membrane of
OHCs is activated by the efferent signal. Although a recent study has
questioned the participation of CGRP in cochlear suppression[57], this
does not rule out the possibility that CFTR is involved in some, as yet
to be elucidated CGRP-related OHC response to efferent signals.
Aside from being a chloride channel, CFTR is also known as a
regulator of dozens of proteins including members in the SLC26
family. For SLC26 members, the interaction-binding site for CFTR's R
domain is the STAS domain located at the C-terminus [30]. Upon
activation by PKA-dependent phosphorylation, the R domain of CFTR
binds to the STAS domain of SLC26 transporters. Like other SLC26
members, prestin also has a STAS domain [33] that could bind to the
activated R domain of CFTR. The present study demonstrated that
CFTR binds to prestin regardless of Fsk treatment, suggesting that
phosphorylation of the R domain is not required for the CFTR-prestin
binding (Fig. 5). This may not be unique to CFTR-prestin binding
because phosphorylation independent binding of the R domain and
the STAS domain of SLC26A3 has been reported recently[58]. The
phosphorylation independent CFTR-prestin binding is compatible
with the idea that CFTR is situated in the basolateral membrane for
some yet to be appreciated physiological purpose. Interaction of R and
STAS domains results in a marked and mutual activation of CFTR and
the SLC26 transporters [30]. For example, regulatory interaction
between the R domain of CFTR and the STAS domain of DRA increases
CFTR's open probability and DRA activity 5–7 fold [30].
For our study of prestin–CFTR interaction, NLCwas used as an index
of prestin's function. The results indicate that mere co-expression of
CFTR does not affect prestin's NLC function. However, with activation
of CFTR, charge displacement by prestin is signiﬁcantly enhanced in a
heterologous expression system. Because theNLCmeasurementswere
performed under saturated and equal chloride concentrations across
the cell membrane, it is unlikely that the increased charge movement
is indirectly caused by a change in local chloride concentration due to
the activation of CFTR. In spite of the fact that prestin did not activate
CFTR's chloride conductance, the results are at least reminiscent of the
modulatory interaction with CFTR reported for other SLC26 family
members.
Although CFTR mRNA and protein have been expressed in various
tissues, and CFTR is reported to regulate the functions of several
different proteins [26,30], mutations of the human CFTR gene mainly
cause only two disease states: cystic ﬁbrosis (CF) and congenital
bilateral aplasia of the vas deferens. Even so, it is pertinent for thisreport to document the incidence of sensorineural hearing impair-
ment in CF patients. It is known that bilateral loss of sensitivity may
develop during CF treatment, especially at high frequencies. However,
this hearing loss is believed to result from damage to hair cells
by aminoglycoside antibiotics such as gentamycin and tobramycin
[59–61] and not from the disease itself. Patients with a severe case of
CF, where a modulatory inﬂuence of CFTR might be observed, receive
aggressive aminoglycoside therapy and, until recently, they usually
had short life spans. This makes it difﬁcult to learn if the CFTR/prestin
interaction inﬂuences peripheral auditory function, especially if the
effects were to be subtle. However, it should also be emphasized that
no signiﬁcant enhancement in charge movement was observed in
isolated OHCs, even though activated CFTR was shown to enhance
prestin's function in transfected mammalian cells. It is possible that
the insigniﬁcant Qmax enhancement observed in isolated OHCsmay be
attributable to a difference in the basal phosphorylation status of CFTR
that may occur in HEK293T vs. OHCs. There are more than ten
phosphorylation sites in CFTR that are regulated by PKA, PKC, and
PKG [23,26]. Thus, it is possible that PKC/PKG phosphorylation
(or dephosphorylation) of CFTR is also required for the modulatory
effect on prestin function. We did not pursue this scenario because
direct phosphorylation of prestin by PKG[35] and PKC (unpublished
observations) also affects prestin function, and consequently, it is not
feasible to separate these concurrent phosphorylation effects. Alter-
natively, the insigniﬁcant increment of Qmax observed in isolated
OHCs might be explained by a mechanism of prestin activation by the
stoichiometric prestin–CFTR interaction suggested above. If the
expression of prestin is much higher than that of CFTR, which is
likely in OHCs, most prestin molecules will not be activated by CFTR
because they lack their binding partner. It is also possible that prestin
is more likely to interact with itself via its C-terminal STAS domain
[62], than with CFTR's R domain. If true, prestin activation by CFTR
might be a vestige of prestin's evolution from transporter to motor
protein. Because it is difﬁcult to generalize from in vitro experiments
demonstrating protein–protein interactions with potential modula-
tory roles in vivo, the impact of the a direct CFTR/prestin association
on peripheral auditory function requires further study.
Although the physiological relevance of prestin activation by CFTR
is not clear, the fact that prestin's nonlinear charge displacement is
enhanced by interaction with CFTR is important for understanding
how the molecule functions as a motor. Knowledge of the molecular
mechanism underlying prestin's nonlinear charge movement and
force generation is a key to comprehending how prestin functions as a
voltage-dependent cochlear ampliﬁer.
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